Raquel Buj

5PUBLICATIONS

33CO-AUTHORS

Haematological tumoursMolecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 27, 2026

αKG-mediated carnitine synthesis drives DNA repair via histone acetylation.

|Jun 13, 2025

ATR promotes mTORC1 activity via de novo cholesterol synthesis.

Naveen Kumar Tangudu, Alexandra N Grumet, Richard Fang

|Feb 20, 2025

Zinc availability in the tumor microenvironment dictates anti-PD1 response in <i>CDKN2A</i> <sup>Low</sup> tumors via increased macrophage phagocytosis.

Raquel Buj, Aidan R Cole, Jeff Danielson

|Apr 16, 2024

De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression.

Naveen Kumar Tangudu, Raquel Buj, Hui Wang

|Apr 30, 2021

Loss of p16: A Bouncer of the Immunological Surveillance?

Kelly E Leon, Naveen Kumar Tangudu, Katherine M Aird

Pageof 1

Frequent Collaborators

Katherine M Aird

Aidan R Cole

Nathaniel W Snyder

Apoorva Uboveja

Richard S Fang

Adam Chatoff

Nadine Hempel

David T Long

Naveen Kumar Tangudu

Hui Wang

Frequent Collaborators

Katherine M Aird

Aidan R Cole

Nathaniel W Snyder

Apoorva Uboveja